Advancing PrEP HIV Prevention Options: From Cabotegravir to Future PrEP Clinical Trails at PENN Prevention 

Event Description

Location: Room 407 

PENN Prevention is a clinical research site within the HIV Prevention Trails Network. We will discuss concluded research trail HPTN 083, which helped secure FDA approval for Cabotegravir as pre-exposure prophylaxis for HIV. Additionally, we will discuss the exciting developments with ongoing and upcoming HIV prevention trails that are currently open for recruitment or anticipated soon at PENN Prevention. Learn about the cutting-edge research initiatives that aim to advance our understanding of HIV prevention and pave the way for innovation in the field. 

Workshop Objectives

1. Explore the impact research studies it could have on community/client base prevention efforts.
2. Gain an understanding of the stages of research. 
3. Have the ability to inform community about opportunities to engage in studies beyond being a participant. 

Presenter

Arianne Morrison